ErbB-dependent regulation of junctional proteins can occur directly through the kinase itself or its downstream pathways, which modulate adhesion in multiple contexts including in cancer cells (Lorch et al., 2004; Klessner et al., 2009) and in response to autoimmune antibodies (Spindler et al., 2018). Here, EGFR is linked to cancer.